Finbarr O’Harte - Concepedia

Author

Finbarr O’Harte

Also Known As

A. Novials, F O'Harte, F O'harte, F P M O'Harte, F P M O’Harte, F P O'Harte, F. O'Harte, F. Oharte, F. P. M. O'Harte, F. P. M. O’Harte

269

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

University of Ulster Queen's University Belfast Creighton University Royal Victoria Hospital University of Limerick

About

Finbarr O’Harte is an author at University of Ulster specializing in medicine, diabetes, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	71	3K
2	Health Sciences	21	32	1.2K
3	Natural Sciences	11	11	496
4	Engineering	1	1	72
5	Public Health	1	1	11

Finbarr O’Harte

127

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Characterization of a Novel Glucose-Responsive Insulin-Secreting Cell Line, BRIN-BD11, Produced by Electrofusion Neville H. McClenaghan, Christopher R. Barnett, Eric Ah-Sing, Diabetes	1996	344
Chemical Ablation of Gastric Inhibitory Polypeptide Receptor Action by Daily (Pro3)GIP Administration Improves Glucose Tolerance and Ameliorates Insulin Resistance and Abnormalities of Islet Structure in Obesity-Related Diabetes Victor A. Gault, Nigel Irwin, Brian D. Green, Diabetes	2005	167
Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes John R. Lindsay, N. A. Duffy, Aine McKillop, Diabetic Medicine	2005	154
Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin Victor A. Gault, Finbarr O’Harte, Patrick Harriott, Diabetologia Metabolic SyndromeInsulin SignalingBiochemistryMedicineInsulin Management	2003	131
Atlantic salmon (Salmo salar) co-product-derived protein hydrolysates: A source of antidiabetic peptides Pádraigín A. Harnedy, Vadivel Parthsarathy, Chris M. McLaughlin, Food Research International BiochemistrySalmo SalarMedicineNatural SciencesDiabetes	2018	121
Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic B-cell line Neville H. McClenaghan, Christopher R. Barnett, Finbarr O’Harte, Journal of Endocrinology Ca2+ InfluxMolecular PhysiologyAmino AcidsBiochemistryMedicine	1996	120
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1 Brian D. Green, Nigel Irwin, Nicola Duffy, European Journal of Pharmacology Diabetes ManagementBiochemistryMedicineDiabetesDipeptidyl Peptidase-iv Activity	2006	114
Demonstration of Glycated Insulin in Human Diabetic Plasma and Decreased Biological Activity Assessed by Euglycemic-Hyperinsulinemic Clamp Technique in Humans Steven Hunter, Alison C. Boyd, Finbarr O’Harte, Diabetes	2003	110
Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice Nigel Irwin, Paula L. McClean, Finbarr O’Harte, Diabetologia ObesityMetabolic SyndromeMedicineInsulin ManagementDiabetes	2007	102
Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo Patrick Harriott, Finbarr O’Harte Journal of Endocrinology	2002	101

Page 1